Eucommia ulmoides extract and soy isoflavones attenuate postmenopausal osteoporosis by modulating bone-specific transcription factors and inflammatory signaling pathways. [PDF]
Front PharmacolZhao R +8 more
europepmc +1 more source
Risk prediction models for postmenopausal osteoporosis: a systematic review and meta-analysis study. [PDF]
BMC Musculoskelet DisordLi L, Lan X, Zeng W, Xu Y, Chen Q.
europepmc +1 more source
Efficacy and safety of denosumab biosimilars in the treatment of postmenopausal osteoporosis: A systematic review of randomized clinical trials. [PDF]
Clin Exp MedShakibaei F +3 more
europepmc +1 more source
A novel circulating osteoimmunological signature for diagnosis: integrating CXCL2, FYN, galectin-3, and STING in postmenopausal osteoporosis. [PDF]
Front PhysiolMa S, Yao Q, Bao X, Li Y.
europepmc +1 more source
Exploration of pathogenesis and targeted drugs of postmenopausal osteoporosis by means of analysis based on reverse network pharmacology. [PDF]
Medicine (Baltimore)Wu D, Zhao W, Ni Y.
europepmc +1 more source
The influence of immune regulation mediated by intestinal microbiota on postmenopausal osteoporosis and intervention strategies. [PDF]
Front Endocrinol (Lausanne)Wang L +5 more
europepmc +1 more source
Kun-Ling Wan Formula Ameliorates Postmenopausal Osteoporosis and Adipose Accumulation by Suppressing mTOR Signaling in Mesenchymal Stem Cells. [PDF]
Pharmaceuticals (Basel)Lu X +16 more
europepmc +1 more source
Bone-targeted celastrol nanocarrier suppresses osteoclastogenesis in postmenopausal osteoporosis. [PDF]
NPJ Sci FoodYu X, Zhang S, Wei Z, Xu Q.
europepmc +1 more source
Nandrolone Decanoate for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Trials. [PDF]
CureusCamara LC, Ferreira MH, Junior NC.
europepmc +1 more source